IP Group PLC
LSE:IPO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Copperleaf Technologies Inc
TSX:CPLF
|
CA |
|
Cineplex Inc
TSX:CGX
|
CA |
|
Veeco Instruments Inc
NASDAQ:VECO
|
US |
|
Kokuyo Camlin Ltd
NSE:KOKUYOCMLN
|
IN |
|
Tecan Group AG
SIX:TECN
|
CH |
|
M
|
Mobase Co Ltd
KOSDAQ:101330
|
KR |
|
New Zealand King Salmon Co Ltd
NZX:NZK
|
NZ |
|
Pexip Holding ASA
OSE:PEXIP
|
NO |
|
Hexatronic Group AB
F:02H0
|
SE |
|
Salter Brothers Emerging Companies Ltd
ASX:SB2
|
AU |
|
A
|
Advanced Human Imaging Ltd
ASX:AHI
|
AU |
|
L
|
Lithium Australia NL
ASX:LITCF
|
AU |
IP Group PLC
Research & Development
IP Group PLC
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
IP Group PLC
LSE:IPO
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Janus Henderson Group PLC
NYSE:JHG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
3i Group PLC
LSE:III
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Schroders PLC
LSE:SDR
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Ninety One PLC
LSE:N91
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Allfunds Group PLC
AEX:ALLFG
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
IP Group PLC
Glance View
IP Group Plc engages in commercializing intellectual properties mainly from its partner universities. The firm's segments include University partnership business and Venture capital fund management. The University partnership business segment is engaged in the commercialization of intellectual property through the formation of long-term partner relationships with universities. The Venture capital fund management segment is engaged in the management of venture funds focusing on the United Kingdom's early-stage technology companies and the provision of corporate finance advice. The firm's life sciences portfolio comprises holdings in approximately 38 companies. Its technology portfolio comprises holdings in approximately 44 companies. The company has three areas of geographic focus, which includes the United Kingdom, the United States, Australia and New Zealand.
